Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-060134
Filing Date
2010-12-14
Accepted
2010-12-14 13:30:44
Documents
1
Period of Report
2010-12-10

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c09664_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c09664_4x0.xml 4 3883
  Complete submission text file 0001209191-10-060134.txt   5847
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYCLACEL PHARMACEUTICALS, INC. 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address
Sosnowski Robert Edward (Reporting) CIK: 0001450497 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 101250093